Compare JBDI & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBDI | EVGN |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | Singapore | Israel |
| Employees | N/A | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5M | 11.1M |
| IPO Year | 2023 | 2013 |
| Metric | JBDI | EVGN |
|---|---|---|
| Price | $2.36 | $0.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.4M | 113.7K |
| Earning Date | 10-15-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $81.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.35 |
| 52 Week High | $9.50 | $1.28 |
| Indicator | JBDI | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 58.81 | 43.02 |
| Support Level | $0.79 | $0.36 |
| Resistance Level | $9.50 | $0.41 |
| Average True Range (ATR) | 0.93 | 0.02 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.79 | 53.55 |
JBDI Holdings Ltd, through its subsidiaries, is mainly engaged in the reconditioning and recycling of containers in Singapore. Its products include reconditioned and new steel drums, plastic drums, carboys, and IBCs with different capacities, and its customers span various industries such as the solvent, chemical, petroleum, and edible oil industries. Additionally, the Group offers ancillary services, such as reconditioning services, wastewater equipment services, and sales of recycled materials and services to complement its core business. The majority of its revenue is derived from the sale of reconditioned containers. Geographically, the Group derives all its revenue from Singapore.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.